Indefinite Delivery Contract SPE2DU25D2210

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D1002, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, is a single-award contract valued at $9,999,999,999 running through December 31, 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
The Indefinite Delivery Contract (IDC) SPE2DR25D3941, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $999,999,999 contract to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The Indefinite Delivery Contract (IDC) SPE2DU25D5136 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award IDC has an ultimate completion date of December 31, 2036 and provides a mechanism for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The Indefinite Delivery Contract (IDC) SPE2DU25D1008 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The solicitation for this IDC, referred to as the Pharmaceutical...
The Indefinite Delivery Contract (IDC) SPE2DR25D3404 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999.00, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet, through the Pharmaceutical Prime Vendor Global Program...
The Indefinite Delivery Contract (IDC) SPE2DU25D5201 was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDC has a ceiling value of $4,999,999 and runs through December 31, 2036. It is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the...
This Indefinite Delivery Contract (IDC) SPE2DR25D3303, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a comprehensive pharmaceutical supply contract valued at $999,999,999 through December 2026. The contract encompasses a broad range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC, running through November 2026, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
The Indefinite Delivery Contract (IDC) SPE2DU25D3408 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This single-award IDC, valued at $4,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish a Pharmaceutical Prime Vendor Global...

The Indefinite Delivery Contract (IDC) SPE2DU25D2210 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to the prime contractor Amerisourcebergen Drug Corp. The IDC has a ceiling value of $4,999,999 and runs through December 31, 2036. It is a single-award contract that will provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The original solicitation for the "Pharmaceutical Prime Vendor Global Program Generation V" covers brand-name, generic, and specialty pharmaceuticals, as well as related medical commodities such as syringes, vials, and test kits. The DLA plans to make multiple primary supplier awards for specific geographic regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet), as well as a single backup supplier award, to ensure supply chain resiliency. The contract will have a 30-month base period with three 30-month option periods, for an estimated total value of $30.3 billion. Awards will be made on a lowest price technically acceptable (LPTA) basis, with a reverse auction strategy used to obtain the best distribution fees.

Generated 6/6/25, 9:51 AM